The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by FRISONI, G. B.
* Articles by TRABUCCHI, M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by FRISONI, G. B.
* Articles by TRABUCCHI, M.
Am J Psychiatry 156:2019, December 1999
© 1999 American Psychiatric Association


Letter to the Editor

Haloperidol and Alzheimer’s Disease

GIOVANNI B. FRISONI, M.D., ANGELO BIANCHETTI, M.D., FEDERICA PIGNATTI, PH.D., ALESSANDRA GOZZETTI, PH.D., and MARCO TRABUCCHI, M.D.
Brescia, Italy

To the Editor: D.P. Devanand, M.D., and colleagues (1) reported successful control with haloperidol of severe behavioral disturbances in outpatients with Alzheimer’s disease. They rightly claimed that "the efficacy of nonpharmacologic interventions...remains to be established" (p. 1513). We wish to support the efficacy of nonpharmacologic interventions on behavioral disturbances with personal data taken from a controlled European study of demented individuals who were admitted to nursing homes.

Special care units for behaviorally disturbed patients with dementia are largely, although not exclusively, based on nonpharmacologic interventions such as appropriate staff attitudes and specific environmental features and have been proposed as an effective model of care. In 1995, the Regione Lombardia of northern Italy funded the establishment of a number of special care units in long-term care facilities. A pilot study show that care in special care units could effectively reduce behavioral disturbances with no increased resort to psychotropic drug load or physical restraints (2). A controlled study has recently been completed that confirms these preliminary results (3).

Patients who were capable of walking and had moderate to severe dementia (Mini-Mental State examination mean score=7, SD=5) and severe behavioral disturbances on the modified Neuropsychiatric Inventory (maximum score=108) were enrolled in 18 special care units (patients, N=39) and 25 traditional nursing homes (control subjects, N=41) (3). The patients were assessed at baseline (10 days after admission) and after 6 months. Although at baseline the patients had more severe behavioral disturbances (modified Neuropsychiatric Inventory mean score=37, SD=18, and mean score=28, SD=12, for patients and control subjects, respectively) (p=0.02), at the follow-up examination, these disturbances had significantly improved in both groups (decrease of 38% and 41%, respectively) (p<0.0001); there was no increase in the percentage of patients taking neuroleptic or other psychotropic drugs. Extrapyramidal signs were not assessed, but proxies of adverse effects of psychotropic medications (cognitive performance and falls) remained unchanged. It is noteworthy that in the patient group, the reduction of behavioral disturbances was achieved with a lower use of physical restraints: 10% of patients and 32% of control subjects (p=0.02) had to be restrained with a chest vest or a belt at follow-up.

Although implementing and testing the efficacy of environmental interventions in outpatients such as those in the study by Dr. Devanand and colleagues is doubtless more difficult than with institutionalized patients, we believe that environmental interventions should be the first-line option for inpatients, whereas they need further investigation in outpatients.

REFERENCES

  1. Devanand DP, Marder K, Michaels KS, Sackeim HA, Bell K, Sullivan MA, Cooper TB, Pelton GH, Mayeux R: A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer’s disease. Am J Psychiatry 1998; 155:1512–1520
  2. Bianchetti A, Benvenuti P, Ghisla KM, Frisoni GB, Trabucchi M: An Italian model of dementia special care unit: results of a pilot study. Alzheimer Dis Assoc Disord 1997; 11:53–56
  3. Frisoni GB, Gozzetti A, Bignamini V, Vellas B, Berger AK, Bianchetti A, Rozzini R, Trabucchi M: Special care units for dementia in nursing homes: a controlled study of effectiveness in cognitive and affective disorders in the elderly. Edited by Cucinotta D, Ravaglia G, ZS-Nagy I. Shannon, Ireland, Elsevier, 1998, pp 215–224



This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
R. Rozzini, G. B. Frisoni, and M. Trabucci
Outcome measurement in mental health: the Italian experience in psychogeriatrics
The British Journal of Psychiatry, November 1, 2002; 181 (5): 442 - 443.
[Full Text]


This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by FRISONI, G. B.
* Articles by TRABUCCHI, M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by FRISONI, G. B.
* Articles by TRABUCCHI, M.


Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org